What is INBS's earnings growth forecast for 2026-2026?
(NASDAQ: INBS) Intelligent Bio Solutions's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 27.28%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,946.83%.
Intelligent Bio Solutions's earnings in 2025 is -$10,866,106.
In 2026, INBS is forecast to generate $337,456 in earnings, with the lowest earnings forecast at $324,222 and the highest earnings forecast at $347,381.
What is INBS's revenue growth forecast for 2026-2026?
(NASDAQ: INBS) Intelligent Bio Solutions's forecast annual revenue growth rate of 542.13% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 4.01%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,436.1%.
Intelligent Bio Solutions's revenue in 2025 is $4,176,082.
In 2026, INBS is forecast to generate $25,347,958 in revenue, with the lowest revenue forecast at $24,353,550 and the highest revenue forecast at $26,093,764.
What is INBS's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: INBS) forecast ROA is 3.36%, which is lower than the forecast US Medical Devices industry average of 10.09%.
What is INBS's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: INBS) Intelligent Bio Solutions's current Earnings Per Share (EPS) is -$17.00. In 2026, INBS's EPS is forecast to hit $0.36 (min: $0.34, max: $0.37).
What is INBS's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: INBS) forecast ROE is 9.32%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.